Literature DB >> 24191972

Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances.

John M Zajecka1.   

Abstract

Remission is the standard of care in major depressive disorder (MDD). However, even in patients who respond to treatment and achieve remission, residual symptoms significantly inhibit functionality and increase the risk of relapse and recurrence. The most common residual symptoms are fatigue, sleep problems, and cognitive dysfunction. Clinicians should be cognizant of these potential residual symptoms and the unique ways in which they present in patients with MDD. Treating these symptoms as target symptoms from baseline increases the patient's chances of an asymptomatic remission. Making use of clinically practical screening instruments and monitoring these target symptoms throughout the course of treatment can improve patients' functional recovery. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24191972     DOI: 10.4088/JCP.12084su1c.02

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  10 in total

Review 1.  Depression and coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Nat Rev Cardiol       Date:  2016-11-17       Impact factor: 32.419

2.  Residual Symptoms After Treatment for Depression in Patients With Coronary Heart Disease.

Authors:  Robert M Carney; Kenneth E Freedland; Brian C Steinmeyer; Eugene H Rubin; Michael W Rich
Journal:  Psychosom Med       Date:  2018-05       Impact factor: 4.312

3.  In pursuit of full recovery in major depressive disorder.

Authors:  Vicent-Gil M; Serra-Blasco M; Navarra-Ventura G; Trujols J; Balanzá-Martínez V; Portella Mj; Cardoner N
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-09       Impact factor: 5.760

4.  Computerized Working Memory Training in Remission From Major Depressive Disorder: Effects on Emotional Working Memory, Processing Speed, Executive Functions, and Associations With Symptoms.

Authors:  Eivind Haga Ronold; Jutta Joormann; Åsa Hammar
Journal:  Front Behav Neurosci       Date:  2022-06-27       Impact factor: 3.617

5.  Addressing sleep problems and fatigue within child and adolescent mental health services: A qualitative study.

Authors:  Nina Higson-Sweeney; Maria Elizabeth Loades; Rachel Hiller; Rebecca Read
Journal:  Clin Child Psychol Psychiatry       Date:  2019-04-08       Impact factor: 2.544

Review 6.  Pharmacological approaches to the challenge of treatment-resistant depression.

Authors:  Dawn F Ionescu; Jerrold F Rosenbaum; Jonathan E Alpert
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

7.  Behavioral Indicators on a Mobile Sensing Platform Predict Clinically Validated Psychiatric Symptoms of Mood and Anxiety Disorders.

Authors:  Skyler Place; Danielle Blanch-Hartigan; Channah Rubin; Cristina Gorrostieta; Caroline Mead; John Kane; Brian P Marx; Joshua Feast; Thilo Deckersbach; Alex Sandy Pentland; Andrew Nierenberg; Ali Azarbayejani
Journal:  J Med Internet Res       Date:  2017-03-16       Impact factor: 5.428

8.  The Role of Campus Data in Representing Depression Among College Students: Exploratory Research.

Authors:  Guang Mei; Weisheng Xu; Li Li; Zhen Zhao; Hao Li; Wenqing Liu; Yueming Jiao
Journal:  JMIR Ment Health       Date:  2020-01-27

9.  A Longitudinal 5-Year Follow-Up Study of Cognitive Function After First Episode Major Depressive Disorder: Exploring State, Scar and Trait Effects.

Authors:  Eivind Haga Ronold; Marit Therese Schmid; Ketil Joachim Oedegaard; Åsa Hammar
Journal:  Front Psychiatry       Date:  2020-12-07       Impact factor: 4.157

10.  Cognitive and affective trait and state factors influencing the long-term symptom course in remitted depressed patients.

Authors:  Christina Timm; Bettina Ubl; Vera Zamoscik; Ulrich Ebner-Priemer; Iris Reinhard; Silke Huffziger; Peter Kirsch; Christine Kuehner
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.